إعلان
إعلان
PCVX
Vaxcyte, Inc. Common Stock
46.47
USDبرعاية
+0.33
+0.72%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
46.48
+0.01
+0.02%
تقارير أرباح PCVX
النسبة الإيجابية المفاجئة
PCVX تفوق 12 من 22 آخر التقديرات.
55%
التقرير التالي
بيانات التقرير القادم
٢٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.51
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-3.21%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+49.50%
Vaxcyte, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, PCVX reported earnings of -1.56 USD per share (EPS) for Q3 25, missing the estimate of -1.29 USD, resulting in a -20.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.49% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -1.51 USD, with revenue projected to reach -- USD, implying an decrease of -3.21% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Vaxcyte, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Vaxcyte, Inc. Common Stock reported EPS of -$1.56, missing estimates by -20.53%, and revenue of $0.00, 0% as expectations.
How did the market react to Vaxcyte, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.49%, changed from $41.35 before the earnings release to $40.32 the day after.
When is Vaxcyte, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٣ فبراير ٢٠٢٦.
What are the forecasts for Vaxcyte, Inc. Common Stock's next earnings report?
Based on 12
analysts, Vaxcyte, Inc. Common Stock is expected to report EPS of -$1.51 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان